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Abstract
Spirometry remains essential for the diagnosis of airway obstruction. Nevertheless, its per-
formance in elderly hospitalized patients with multimorbidity can be difficult. The aim of this
study is to assess the utility of the COPD-6 portable device in this population. We included
all patients hospitalized for exacerbation of chronic diseases in a medical ward specialized
in the care of multimorbidity patients, between September 2017 and May 2018. A question-
naire including sociodemographic, cognitive and functional impairment, among other vari-
ables, was completed the last day of admission. Subsequently, patients attempted to
perform three valid respiratory manoeuvres with the COPD-6 device and then conventional
spirometry. A total of 184 patients were included (mean age of 79.61 years, 55% men).
Forty-seven (25.54%) patients were able to perform complete spirometric manoeuvres and
99 (53.8%) could perform a valid FEV1/FEV6 determination. The inability to perform a valid
spirometry was related with the patient’s age, functional physical disability, cognitive
impairment or the presence of delirium or dysphagia during admission. Only 9% of patients
with a Mini Mental Cognitive Examination (MMEC) lower than 24 points could perform a
valid spirometry. Of the patients with an MMEC < 24 points and unable to perform spirome-
try, 34% were able to complete the FEV1/FEV6 manoeuvres. No differences were found in
the Charlson index, multimorbidity scale, number of domiciliary drugs, or length of stay
between those patients able and those not able to perform respiratory manoeuvres. The
agreement between the values for FEV1 measured with COPD-6 and those observed in
the spirometry was good (r: 0.71; p<0.0001). Inability to perform a valid spirometry during
hospitalization in elderly patients with multimorbidity is frequent and related with functional
and cognitive impairment. FEV1/FEV6 determination using the COPD-6 portable device
allows an important percentage of the patients with limitations to complete spirometric
measurement.
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Introduction
Improvement in socioeconomic status, alongside progress in the management of chronic dis-
eases and better care for decompensation, is associated with a sustained increase in life expec-
tancy in developed and emerging countries [1]. This longer survival is linked to a marked
increase in the prevalence of elderly patients with multiple concomitant chronic illnesses.
Recent studies have shown that the mean of these chronic diseases in the general population
over 80 years is about 5 pathologies, rising to 8 in hospitalized patients [2,3].
This fact has led to the search for new terminologies and concepts to replace the classic defi-
nition of comorbidity–understood as a primary disease with other secondary pathologies asso-
ciated with it–given the difficulty in deciding which one is the predominant disease in an
individual patient. Regarding these new proposed concepts, several authors have suggested the
term multimorbidity as being more appropriate, defined as the presence of two or more con-
comitant long-term diseases in the same patient [4].
Chronic respiratory diseases account for an important percentage of multimorbidity,
although compared with other chronic diseases pulmonary disorders are often underdiag-
nosed [2–8]. The causes of this misdiagnosis are, among others, the lack of suspicion and the
need to perform a valid spirometry to confirm the diagnosis, in many of them, of Chronic
Obstructive Pulmonary Disease (COPD). Although spirometry is a simple and widely available
technique, its performance in frail elderly patients can be difficult, especially due to the inabil-
ity to maintain expiratory flow until complete exhalation. Depending on the population stud-
ied, between 20 and 80% of elderly patients are unable to complete a satisfactory spirometry
[9,10].
In recent years, several handheld spirometers have been developed. Usually these spirome-
ters measure the FEV1/FEV6 ratio, requiring less effort and allowing the recovery of the 25% of
patients unable to complete forced vital expiration [11,12]. These devices have proven useful
in the screening for respiratory obstruction and have shown an excellent correlation with con-
ventional spirometry [13]. However, current evidence of the utility of FEV1/FEV6 for the diag-
nosis of airway obstruction in multimorbid patients hospitalized for decompensation of
chronic diseases is scarce [12].
Our main objective was to study the utility and reliability of FEV1/FEV6 in the diagnosis of
airway obstruction in patients hospitalized with multimorbidity, and the variables associated
with the inability to successfully perform valid manoeuvers to determine FEV1/FEV6 with
COPD-6 and FEV1/FVC with conventional spirometry.
Methods
The present study was performed between September 1, 2017 and May 31, 2018, in a hospitali-
zation medical ward specialized in the care of multimorbidity patients in the University Hospi-
tal Mutua de Terrassa, in Terrassa, Spain. We included the first admission of all patients
hospitalized for exacerbation of chronic disease with two or more criteria of multimorbidity
according to the functional definition of the Andalusia Health Department. This classification
includes 15 chronic pathologies selected for relevant severity or impact on daily living activities
(Table 1) [14]. On the last day of hospitalization patients or their caregivers completed a ques-
tionnaire specifically designed for the study. The questionnaire was administered by trained
investigators. A previous pilot study was performed to guarantee their viability [12]. This ques-
tionnaire included medical and socioeconomic variables, smoking history, prior diagnosis of
chronical respiratory disease, results of the most recent spirometry if available, and domiciliary
treatment. Multimorbidity assessment was evaluated using the multimorbidity classification of
the Andalusia Health Department, the Charlson index, a scale for other comorbid conditions
FEV1/FEV6 index in hospitalized patients with multimorbidity
PLOS ONE | https://doi.org/10.1371/journal.pone.0220491 August 2, 2019 2 / 16
Zeneca Spain. This does not alter our adherence to
PLOS ONE policies on sharing data and materials.
not included in the Charlson index, and the PROFUND index [14–17]. The PROFUND index
is a multicomponent prognostic scale designed and validated for patients with multimorbidity,
and which includes variables such as age, presence of caregiver, dyspnoea, delirium during
admission, physical functional dependence, and number of hospitalizations in the previous
year. The score ranges from 0 to 36 points [17] “S1 Table”. Physical functional status was
assessed with the Barthel index, while cognitive status was measured using the Pfeiffer test and
the Mini Mental Cognitive Examination in the Spanish version of Lobo et al. (MMCE) [18–
20]. MMCE is analogous to the original Mini Mental State Examination of Folstein et al. and
Table 1. Multimorbidity functional criteria of the Andalusia Health Department.
Category A
1. Heart failure in functional NYHA class II or higher.
2. Ischaemic heart disease.
Category B
1. Autoimmune diseases or systemic vasculitis.
2. Chronic kidney disease defined by elevated creatinine
(> 1.4 mg/dl in men or> 1.3 mg/dl in women) or proteinuria,
maintained for 3 months.
Category C
1.-Chronic respiratory disease in clinically stable situation with
dyspnoea measured with the mMRC scale�2 or
FEV1 <65%, or SaO2� 90%.
Category D
1. Inflammatory bowel disease.
2. Symptomatic liver disease
(signs of portal hypertension or liver failure) or chronic activity.
Category E
1. Cerebrovascular attack.
2. Motor neurological disease that causes
a permanent deficit limitation for basic daily life activities. (a)
3. Neurological disease with permanent cognitive impairment,
at least minimally moderated (b).
Category F
1. Symptomatic peripheral artery disease.
2. Diabetes mellitus with proliferative retinopathy or
symptomatic neuropathy. (c)
Category G
1.-Chronic anaemia with digestive loss or acquired blood disorder
with Hb <10 g/dl, in at least two determinations separated by
three months.
2. Solid or haematologic neoplasia not susceptible to active
treatment with curative purposes.
Category H
1.-Chronic osteoarticular disease that causes a limitation of
basic life activities.
Excluded: patients in a transplant program, and those on dialysis
or with AIDS.
a) Barthel Index <60 points.
b) Barthel Index <60 points and/or cognitive impairment minimally
moderated (5 or more errors in Pfeiffer test).
c) Presence of proliferative retinopathy, albuminuria, cerebral stroke,
or symptomatic neuropathy.
https://doi.org/10.1371/journal.pone.0220491.t001
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maintains the same structure of evaluation of 6 cognitive abilities, but it also includes 5 more
questions, three of them referring to the examination of attention and calculation, and the
remaining two to language, with a maximum score of 35 points; this version maintains strong
concordance with the original Mini Mental State Examination. As well as recording the overall
MMCE score, the intersecting pentagon (IP) drawing component of the MMCE and Mini
Mental State Examination and the writing sentence of the same tests were analysed separately.
For the IP figure to be considered correct the patient must make a copy of the printed diagram.
All 10 angles must be present and 2 must intersect; tremor and rotation are ignored. For the
sentence writing, the researcher asks the patient to write a sentence, without dictating it. The
sentence must contain a subject and a verb, and must make sense. Correct grammar and punc-
tuation are not necessary.
Delirium was diagnosed with the confusion assessment method and dysphagia was evalu-
ated by a speech therapist [21].
Measurement of the functional parameters, FEV1, FEV6, and FEV1/FEV6 ratio, was per-
formed using the portable COPD-6 device (model 4000, Vitalograph Ltd., Ennis, Co. Clare,
Ireland). The patient was required to perform manoeuvers in a similar way to those used in
forced spirometry, with the difference that it was only necessary to maintain exhalation for the
first 6 seconds. Measurements were repeated a maximum of 8 times, or until at least 3 reliable
measurements were achieved [13]. The best values obtained for each patient were recorded. If
3 valid manoeuvers were not achieved after 8 attempts the patient was considered unable to
perform the technique.
Subsequently, patients who were able to use the device correctly underwent conventional
spirometry, using a portable spirometer (Datoespir micro, Sibelmed, Barcelona Spain). The
test was performed in accordance with the Spanish Society of Pulmonology and Thoracic Sur-
gery (SEPAR) guidelines [22]. Of the first 20 patients who were unable to perform FEV1/
FEV6, none could perform the conventional spirometric manoeuvers correctly, so we did not
attempt the test with the other patients unable to perform the COPD-6 procedures. If they
were not able to maintain expiration for 6 seconds, it was considered that they could not do a
complete forced expiration. The manoeuvers to determine FEV1 are similar for the two tech-
niques. COPD-6 maneuvers were performed by two of the principal investigators (SK, PA),
that are previously trained in COPD-6 use. Conventional spirometry was performed by a
nurse specialized in pulmonary function tests. Respiratory maneuvers were performed without
changing the treatment of the patients. Specifically, in patients under bronchodilator treat-
ment, the values collected for COPD-6 and conventional spirometry refer to post-bronchodila-
tor measures.
The exclusion criteria were death during hospitalization or presenting other reasons, apart
from cognitive or functional impairment, which prevented the realization of FEV1/FEV6 (e.g.,
tracheotomy, facial paralysis....).
Statistical analysis
Qualitative variables were expressed as absolute frequencies and percentages, while quantita-
tive variables were summarized as mean and standard deviation (SD) in the case of normally
distributed or median and interquartile range 25–75%. Comparison among means was made
with the ANOVA test for independent samples with a parametric distribution or non-
parametric test (Mann-Whitney U or Kruskal-Wallis) for variables not distributed normally.
When the independent variable had more than 2 conditions, the Bonferroni or Games-Howell
tests were used according to the homogeneity of the variances. Either the x2 test or the Fisher
exact test was used for the comparison of proportions. Correlations between quantitative
FEV1/FEV6 index in hospitalized patients with multimorbidity
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variables were determined with the Pearson or Spearman’s correlation test. Multivariable
logistic analysis for the identification of independent correlates of outcomes was performed
with stepwise linear regression models. Variables entered in the model were chosen based on
univariant analysis results.
Receiver operating characteristic (ROC) curves and their area under the
curve
(AUC) were also analysed. The comparison of AUC was performed with the DeLong method.
Statistical significance was determined for p-values below 0.05.
In the first approach using analysis of paired means, with a bilateral contrast, an usual nom-
inal level of 0.05 (Type I error, alpha) and a power of 0.9 (Type II error, beta, of 0.1) the num-
ber of patients needed would be 199. Following the guides for reporting statistics in
observational studies (STROBE), no multitesting corrections were applied. The analysis was
performed using MedCalc Statistical Software for Windows (MedCalc Software bvba.
Belgium)
The STROBE check-list for cross-sectional studies is detailed in a supporting information
file “S2 Table”. The researchers read and gave written explanations of the study and informed
consent to the patient, and in case of impossibility due to physical or cognitive impairment to
the caregiver. The signature was always made in the presence of the researcher and the patient.
Both documents, the written explanations and informed consent, were approved by the ethics
committee.
The protocol was registered in ISRCTN with the number ISRCTN10703543. The study was
classified by the Spanish agency of medicines and health products as an observational study
and was approved by the Ethics and Clinical Trials Committee of University Hospital of the
Mutua de Terrassa.
Results
Overall, 197 patients met the inclusion criteria, of whom 184 were finally included. Thirteen
patients (6.6%) were excluded due to missing data or not giving informed consent “Fig 1.”
Excluded patients had better functional capacity and lower cognitive impairment according to
the Barthel index and the Pfeiffer and MMCE scales, without differences in terms of age, gen-
der, or Charlson index.
Mean age of the studied population was 79.61 years (SD: 12.42; Interquartile range 25%-
75%: 74–88), and 101 (55%) were males. The mean for chronic diseases in the multimorbidity
scale was 3.1 (SD: 1.57), with the most frequent being heart failure (56.3%) and chronic respi-
ratory diseases (54.33%). The mean of the Charlson index without age adjustment was 4.32
(SD: 2.38). Demographic and clinical characteristic are detailed in Table 2. The most frequent
combination of chronic diseases was the coexistence of heart failure with chronic respiratory
diseases (65 patients, 35%), heart failure with renal failure (49 patients 26.7%), chronic respira-
tory disease with renal failure (41 patients, 22.8) and heart failure with ischaemic heart disease
(36 patients, 19.7%). The relationship between the various chronic diseases is shown graphi-
cally in “Fig 2”.
A total of 85 patients (46.2%) were unable to perform valid manoeuvres with COPD-6 to
measure FEV1/FEV6 ratio. The other 99 patients were able to correctly perform FEV1/FEV6
and of them 47 (47.5%) were also able to complete a spirometry. Therefore, 28.3% of the total
number of patients included were able to perform FEV1/FEV6 with the handheld COPD-6
device but not with conventional spirometry “Fig 1”.
FEV1/FEV6 index in hospitalized patients with multimorbidity
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The researchers considered the main cause of being unable to correctly perform the FEV1/
FEV6 to be dementia in 67.5% of the cases, functional impairment in 22.5%, and lack of collab-
oration in 10%.
Fig 1. Flowchart of participants.
https://doi.org/10.1371/journal.pone.0220491.g001
Table 2. Comparison of patients who can and cannot correctly complete the COPD-6 manoeuvers.
VARIABLE p-value
Non-valid COPD-6 (n = 85) Valid COPD-6 (n = 99)
Age (SD) 81.26 (13.20) 78.19 (11.58) 0.004
Gender
Men 62 (62.6%) 39 (45.9%) 0.017
Women 37 (37.4%) 46 (54.1%)
Barthel (SD) 36.48 (33.69) 70.39 (27.67) <0.0001
Pfeiffer (SD) 5.98 (4.03) 1.62 (2.07) <0.0001
MMSE (SD) 16.44(11.91) 28.15 (6.57) <0.0001
MMCE sentence incorrect 71 (83.5%) 27 (27.3%) <0.0001
MMCE pentagons incorrect 71 (83.5%) 41 (41.4%) <0.0001
Length of admission, days (SD) 9.64 (5.99) 10.07 (6.13) 0.3
Domiciliary drugs (SD) 8.55 (4.23) 9.03 (4.05) 0.4
Multimorbidity criteria (SD) 3.09 (1.64) 3.09 (1.51) 0.9
Charlson age adjusted (SD) 7.98 (2.99) 7.59 (2.71) 0.3
Charlson not adjusted 4.42 (2.63) 4.23 (2.16) 0.5
PROFUND 14.86 (5.72) 7.92 (5.43) <0.0001
Delirium 54 (63.5%) 25 (25.3%) <0.0001
Dysphagia 52 (61.2%) 19 (19.4%) <0.0001
https://doi.org/10.1371/journal.pone.0220491.t002
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The differences between the 3 groups of patients (1. patients unable to perform valid
COPD-6 manoeuvers; 2. patients with valid COPD-6 and incorrect conventional spirometric
procedure, and 3. patients able to perform both techniques correctly) were significantly and
linearly related with age, functional capacity measured with the Barthel index, cognitive
impairment assessed with the Pfeiffer and the MMCE, and scores on the PROFUND prognos-
tic scale (all p<0.05). Only 9% of patients with an MMEC of< 24 points could perform a valid
spirometry. Of the 35 patients with an MMEC < 24 points unable to perform spirometry, 12
(34%) could complete FEV1/FEV6 manoeuvers. Women, those who could not correctly com-
plete the sentence or PI figure on the MMCE, and those who presented delirium or dysphagia
during admission were also less likely to successfully complete both COPD-6 and conventional
spirometry (all p<0.0001). No differences were found in the Charlson index, multimorbidity
scale, number of chronic domiciliary drugs, or length of stay between those patients able to
and those not able to perform respiratory manoeuvers “Fig 3”.
In a separate analysis, patients unable to perform the manoeuvers of COPD-6 acceptably
compared with those who could determine the FEV1/FEV6 correctly were significantly older,
with lower functional capacity, worse scores on scales of cognitive impairment, higher scores
on the PROFUND index, and greater incidence of delirium and dysphagia during the hospital
stay (Table 3). In this analysis the AUC for the capacity to correctly perform COPD-6 manoeu-
vers was 0.79 with a 95% confidence interval (CI) of 0.69–0.89 for the MMCE, 0.78 (CI 95%:
0.71–0.85) for the Barthel index, and 0.80 (CI 95%: 0.74–0.87) for the PROFUND scale “Fig 4”.
The respective ROC curves of these variables were similar without statistical significance. In
the multivariate model, after adjustment for age, gender, Barthel, and PROFUND, only
Fig 2. Correlation between different chronic diseases, according to multimorbidity scale. The size of the spheres represents the
prevalence of diseases (HF = Heart failure, CRD = Chronic respiratory diseases, IHD = Ischaemic heart disease, CKD = Chronic
kidney diseases, DEM = Dementia, ND = Neurological diseases, DM = Diabetes mellitus, PAD = Peripheral arterial disease,
NP = Neoplastic diseases, AD = Autoimmune diseases, O = Osteoarticular diseases). Joined lines represent the strength of the
correlation expressed as a percentage of the total.
https://doi.org/10.1371/journal.pone.0220491.g002
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MMEC maintained statistical significance (p<0.0001). Patients unable to correctly complete
the MEC sentence or IP figure had less probability of completing valid COPD-6 manoeuvers
(both p<0.0001) with a sensitivity and specificity of 72.7% and 84.7% for the sentence and a
sensitivity of 63.7% and specificity of 81.7% for the IP figure, respectively.
The same variables were associated with the inability to complete a valid spirometry test in
those patients who previously could correctly perform COPD-6 determinations (Table 3).
After adjustment for MMCE, Barthel and PROFUND index, only age retained statistical sig-
nificance (p = 0.01). In this analysis patients who were able to perform both techniques com-
pared with those who could only complete COPD-6 had better FEV1 and FEV6 but a higher
degree of airflow obstruction measured with the FEV1/FEV6 ratio (Table 3).
The agreement between the values for FEV1 measured during hospitalization with COPD-6
and those observed in the conventional spirometry was good (Pearson correlation: r: 0.71;
p<0.0001). Of the 52 patients with a valid COPD-6 who could not perform the spirometry, in
29 cases a previous spirometry could be recovered, so in 76 cases the diagnosis of obstruction
defined by FEV1/FVC <0.7 could be compared with the values obtained in FEV1/FEV6. The
correlation between FEV1/FEV6 and FEV1/FVC was confirmed as good (r:0.643; p<0.0001).
The different values for sensitivity and specificity for the diagnosis of airflow obstruction
defined as FEV1/FVC<0.7 and several cut-offs of the FEV1/FEV6 between 0.68 and 0.84 are
shown graphically in “Fig 5”.
Fig 3. Differences between variables and ability to perform respiratory manoeuvers. �p<0.0001; # p<0.05.
Sentence = unable to correctly complete sentence of MMCE. IP drawing = unable to correctly produce IP drawing of
MMCE. � # red = bivariate analysis. � # blue = adjusted for multiple variables.
https://doi.org/10.1371/journal.pone.0220491.g003
Table 3. Comparison of patients with valid COPD-6 who can and cannot correctly complete conventional spirometric test.
VARIABLE p-value
Non-valid spirometry (n = 52) valid spirometry (n = 47)
Age (SD) 81.01 (9.54) 75.02 (12.84) 0.009
Gender
Men 25 (40.3%) 37 (59.7%) 0.001
Women 27 (73%) 10 (27%)
Barthel (SD) 63.27 (24.41) 78.27 (29.14) 0.006
Pfeiffer (SD) 2.27 (2.19) 0.89 (1.67) 0.0001
MMSE (SD) 27.04 (6.34) 29.67 (6.67) 0.03
MMCE sentence incorrect 21 (77.8%) 6 (22.2%) 0.002
MMCE pentagons incorrect 34 (82.9%) 7 (17.1%) <0.0001
Length of admission, days (SD) 11.33 (7.74) 8.58 (2.81) 0.4
Domiciliary drugs (SD) 8.32 (3.89) 9.88 (4.10) 0.65
Multimorbidity criteria (SD) 3.26 (1.65) 2.91 (1.32) 0.28
Charlson age adjusted (SD) 8 (2.55) 7.13 (2.84) 0.1
Charlson not adjusted 4.13 (2.16) 4.33 (2.18) 0.5
PROFUND 9.38 (5.75) 6.15 (4.48) 0.04
Delirium 22 (88%) 3 (12%) <0.0001
Dysphagia 16 (84.2%) 3 (15.8%) 0.002
FEV1 (ml) 1.195 (648) 1.001 (614) 0.03
FEV6 (ml) 1.671 (784) 1.386 (717) 0.04
FEV1/FEV6 69.7 (15.3) 75.7 (12.5) 0.04
https://doi.org/10.1371/journal.pone.0220491.t003
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Fig 4. Comparison of ROC curves for Barthel (blue line), MEC (green line), and PROFUND (orange line), and probability of completing
FEV1/FEV6 manoeuvers.
https://doi.org/10.1371/journal.pone.0220491.g004
Fig 5. Sensitivity and specificity of different thresholds of FEV1/FEV6 and airway obstruction defined as FEV1/FVC<0.7.
https://doi.org/10.1371/journal.pone.0220491.g005
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Finally, using the cut-off point recommended in the literature for the diagnosis of airway
obstruction with FEV1/FEV6 (<0.73), 43 (43.4%) patients met the obstruction criteria, of
whom 15 (34%) were not previously known.
Discussion
The data from the present study corroborate the difficulty of correctly performing the expira-
tory manoeuvers necessary to diagnose airflow obstruction during hospital admission in a
population that is increasingly prevalent: elderly patients with multimorbidity. This incapacity
is closely related with the presence of cognitive and functional impairment, especially frequent
in these patients, but not with the number of multimorbidity criteria. Our study also reinforces
the usefulness of FEV1/FEV6 in a large number of patients unable to perform conventional spi-
rometry and confirms the high rate of underdiagnosis of pulmonary obstruction in these
patients.
The present study, together with a small previous pilot study conducted by our group, is the
first to assess the difficulty in performing spirometry and also the usefulness of FEV1/FEV6 in
hospitalized patients with multimorbidity [12]. The most frequent definition of multimorbid-
ity is the coexistence in the same patient of two or more chronic diseases [4,23]. Another
approach recommended by the NICE guidelines is to consider, in addition to the number of
chronic diseases, other factors such as fragility, polypharmacy, and complexity of care [24]. In
our case the definition of multimorbidity was based on a scale that accounts not only for the
number of chronic diseases but also their severity and impact on patients’ functional capacity
[14]. Additionally, we used one of the most recognized comorbidity scales, the Charlson index
[16]. Our data show that multimorbidity by itself is not associated with a higher prevalence of
patients unable to perform spirometric manoeuvers. The best predictors for the inability to
perform a quality spirometry are age, cognitive impairment, and physical functional disability,
all of which are also closely related to each other.
With respect to age, the percentage of elderly subjects able to perform a classical spirometry
with the established quality criteria varies widely depending on the population studied, rang-
ing between 22% and 93% [9,10,25–31]. Some of these studies selected populations of healthy
elderly and show that age by itself does not prevent the performance of quality spirometry,
although obviously the prevalence of cognitive impairment, chronic diseases, and frailty rises
with age. In light of this, Pezzoli et al., in a study conducted in ambulatory elderly patients
recruited in a geriatric outpatient unit, found that 80% were able to perform a quality spirome-
try, although the time needed to do so was 20–30 minutes—practically double the time needed
for young patients. In this study the mean age of the patients was 75 and the prevalence of cog-
nitive impairment (defined as an MMSE <21) was as low as 1.5% [25]. Similar results were
reported by Bellia et al. in a cohort of 1,622 outpatients over 65 years of age recruited in geriat-
ric institutions [9]. Our results are more comparable to those of Allen et al., in a cohort of
patients hospitalized in a rehabilitation ward with a mean age of 80. In that study the authors
showed that only 22% of patients were able to complete a spirometry with the validity criteria
established by the American Thoracic Society, although 67% were able to perform the FEV1
manoeuvers correctly. Of note, this prevalence should be even lower since patients with an
MMSE <11 were excluded from the study [10]. The exclusion of patients with different
degrees of dementia—a characteristic common to all previously published studies—generates
a selection bias and makes it difficult to uncover the true percentage of patients capable of per-
forming the technique. In our study, we decided not to exclude patients with dementia in
order to learn the real percentage of patients unable to perform spirometry, although obviously
those with greater cognitive impairment were already expected to be unable to collaborate in
FEV1/FEV6 index in hospitalized patients with multimorbidity
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the realization of the technique. Of note, in our study age was non-significant after multivari-
ate analysis for the possibility of performing COPD-6, but retained its significance after adjust-
ment for Barthel, MMCE, and PROFUND for the capacity to successfully complete a
spirometry in patients who previously were able to complete manoeuvers for FEV1/FEV6.
The relationship between cognitive impairment and the inability to perform spirometry
manoeuvers is well known. In fact, some authors have suggested that dementia screening
should be performed in patients who, for no obvious reason, cannot perform a valid spirome-
try test [29]. However, the confirmation of an obstructive pattern is necessary to confirm some
respiratory diseases such as COPD. This leads to a paradoxical situation: while longitudinal
studies show an increase in the incidence of dementia in patients with COPD, in cross-sec-
tional studies the prevalence of dementia is relatively small, given that the patients cannot per-
form quality spirometry and are therefore excluded from the studies [15,32].
The test most widely used in previous research to measure the relation between cognitive
impairment and the impossibility of performing a complete spirometry is the MMSE or its
adaptations [26–31]. In this test, values lower than 24/30 are usually considered indicative of
cognitive impairment—a threshold shared with the Spanish version. Our study confirms these
previous data in that only 9% of patients with an MEC of< 24 points could perform a valid
spirometry. Our study also reinforces the results of two previous studies of the usefulness of
the sentence and the IP drawing of MMSE as rapid detection tests for the impossibility of per-
forming spirometry [10,27]. Only 6% of patients with an incorrect sentence and 7% with an
incorrect IP drawing were able to complete the technique.
The main impediment to performing conventional spirometry in these patients is the
inability to maintain expiratory flows until completion of the forced expiration. Handheld spi-
rometer devices allow assessment of the airflow obstruction based only on the first 6 seconds
of expiration, so the quotient is obtained by dividing the FEV1/FEV6 instead of the classically
used FEV1/FVC. Their usefulness in screening for COPD and concordance with the values
obtained in classical spirometry have been well demonstrated in several studies conducted in
the general population [13, 33–38]. In fact, FEV1/FEV6 is a more reliable index than FEV1/
FVC in longitudinal studies, because FVC is more variable for the differences in the duration
of the forced exhalation [39]. In elderly patients the prognostic value of a low FEV1/FEV6 is
comparable to that of a low FEV1/FVC and FEV1 [40].
Beyond its usefulness in obstruction screening, another less explored advantage of FEV1/
FEV6 is the capacity to recover a percentage of patients unable to perform a complete spirome-
try, although information on this point is scarce. In a study performed in elderly patients,
FEV1/FEV3 allowed recovery of 25% of patients unable to perform spirometry, including some
with an MMSE <24 [10]. In another study performed in 1,531 outpatients with a mean age of
74, valid FVC measurements were achieved in 56.9% with the spirometric test, while this per-
centage increased to 82.9% with the FEV6 [11]. In yet another study performed on hospitalized
patients with multimorbidity, 65% of the patients successfully performed FEV1/FEV6 with
another handheld device (Piko 6 nSpire Health, Inc, Germany) [12]. In our study of the 99
patients with a valid FEV1/FEV6, 47 (47.5%) were unable to perform complete expiratory man-
oeuvers, and 34% of the patients with an MMEC < 24 points who were unable to perform spi-
rometry were able to complete FEV1/FEV6 manoeuvers. Similarly, the percentage of patients
with an incorrect IP drawing increased from 22% for the determination of FEV1/FEVC to 78%
for FEV1/FEV6.
In our study, we compared the values for FEV1 measured consecutively with COPD and
spirometry only in those patients who were able to perform both techniques during the hospi-
tal stay in question, since FEV1 values vary with time and exacerbations. Nevertheless, to con-
firm the classic diagnosis of airway obstruction (FEV1/FVC <0.7), we used the current
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spirometry data in patients able to perform a valid spirometry during the stay in question or,
alternatively, considered a previous spirometry from the clinical history if one was recovered.
In both cases, our study confirms the strong correlation between values observed in the FEV1
measured with the two methods and the diagnosis of airflow obstruction measured with the
FEV1/FEV6 and FEV1/FVC.
Other predictors of the inability to perform short, complete spirometric expiration man-
oeuvers in our study were female gender and the presence of delirium or dysphagia during
admission. The increased difficulty of elderly women in completing expiratory manoeuvers
has already been reported in other studies [11]. As to delirium and dysphagia, they are markers
of frailty and are frequent during hospital stays in elderly patients with chronic diseases.
Our study has some limitations that need to be considered. First, it was performed in a sin-
gle hospital with a specific ward for attention to patients with multimorbidity. Therefore our
results may not be extrapolated to patients hospitalized in other services. However, the per-
centage of patients capable of performing spirometry is comparable to other studies performed
in a similar population [10]. Second, our research was carried out during a hospital admission
—a situation that generates an increase in weakness with impaired functional capacity and a
higher incidence of delirium and dysphagia [41–44]. It is likely that an indeterminate number
of patients who could not complete the spirometry manoeuvers during a hospital stay could
do so in the following months if their functional capacity improved. Although the clinical
guidelines recommend performing spirometry in a stable phase, at least one month after hos-
pitalization, in this population this is often not feasible, due to difficult logistics, hospital read-
missions, and death. In the follow-up of the present cohort, 30% of the patients were deceased
or had been readmitted during the month after hospital discharge. This approach allows us to
avoid the unresponsive bias. However, the diagnosis of obstruction performed during admis-
sion with the COPD-6 is closely related to the values obtained with conventional spirometry at
6 weeks after discharge. In two recent studies performed in hospitalized patients with FEV1/
FVC< 70% during admission the obstructive airflow pattern in conventional spirometry per-
sisted during the follow-up. Of note, in these studies nearly half of the subjects did not attend
the follow-up visit [45,46]. After finding that the first 20 patients unable to perform COPD-6
were also unable to perform spirometric manoeuvers, we did not attempt to perform spirome-
try in the rest of the patients without a valid COPD-6 determination. This is reasonable, since
if they were not able to maintain expiration for 6 seconds it was considered that they could not
achieve a complete forced expiration.
Finally, in our study, we did not analyse the bronchodilator test for two reasons. First so as
not to fatigue patients after the maneuvers of COPD-6 and spirometry. Performing the bron-
chodilator test would double the number of procedures. Second, it is advisable to stop bron-
chodilator treatment from performing the bronchodilator test in patients who are not
stabilized. However, practically all patients classified as obstructive performed both measure-
ments (COPD-6 and conventional spirometry) under bronchodilator treatment.
In conclusion, our study demonstrates the difficulty of performing spirometric manoeuvers
in a significant percentage of elderly patients with multimorbidity hospitalized for decompen-
sation of their chronic diseases. Nevertheless, a significant number of these patients can per-
form simpler manoeuvers that also correlate well with conventional spirometry data, such as
FEV1/FEV6.
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